SAA2 and obesity disorder: Chronic, low-grade inflammatory conditions such as diabetes, rheumatoid arthritis, obesity, and atherosclerosis are characterized by elevated circulating levels of SAA that is associated with increased risk of cardiovascular disease (CVD) [38].